scispace - formally typeset
H

Heung Chong

Researcher at St Thomas' Hospital

Publications -  9
Citations -  773

Heung Chong is an academic researcher from St Thomas' Hospital. The author has contributed to research in topics: Immune system & Genetic enhancement. The author has an hindex of 8, co-authored 9 publications receiving 760 citations.

Papers
More filters
Journal Article

Systemic Gene Therapy of Murine Melanoma Using Tissue Specific Expression of the HSVtk Gene Involves an Immune Component

TL;DR: It is reported here that the number of recently established lung metastases of B16 melanoma in C57BL mice treated with ganciclovir is reduced compared to controls after multiple i.v. administrations of high titer retroviral supernatant encoding the HSVtk gene, but not after administration of liposome-complexed plasmid DNA.
Journal ArticleDOI

Generation of an anti‐tumour immune response in a non‐immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1‐like profile of intratumoural cytokine expression

TL;DR: Data show that B16/HSVtk+ cells die predominantly by necrosis, rather than apoptosis, on exposure to GC, a process which may be associated with the generation of anti‐tumour inflammatory responses, and discuss the development of improved vectors for gene therapy to augment these effects in vivo.
Journal ArticleDOI

Tumour cell expression of B7 costimulatory molecules and interleukin-12 or granulocyte-macrophage colony-stimulating factor induces a local antitumour response and may generate systemic protective immunity.

TL;DR: It is shown that expression of B7–2 led to a local antitumour response as well as significantly raised systemic immunity, and combining costimulatory molecules and cytokines may be a useful therapeutic approach in some, but not all tumours.
Journal Article

Replication-competent retrovirus produced by a 'split-function' third generation amphotropic packaging cell line.

TL;DR: To the authors' knowledge, this is the first report of RCR arising from routine use of GP + envAM12 cells or any similar third generation packaging line and has important implications for the use of such lines in human gene therapy protocols.
Journal ArticleDOI

Expression of co-stimulatory molecules by tumor cells decreases tumorigenicity but may also reduce systemic antitumor immunity.

TL;DR: It is shown that expression of a member of the B7 family of co-stimulatory molecules by CMT93 murine colorectal tumor or 1735 murine melanoma cells resulted in a local antitumor response in immunocompetent mice, suggesting that some caution is appropriate when considering the use of these molecules in the gene therapy of cancer.